Clinical Trial Update: Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports ongoing evaluation of intranasal oxytocin for chronic pain in Phase 2 and Phase 3. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: Memorial University of Newfoundland | Conditions: Chronic Pain | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING